Source: Annual Congress 2004 - Advancements in pathobiology of respiratory diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Domagala-Kulawik, G. Hoser, R. Chazan (Warsaw, Poland). Apoptosis of circulating and BALF lymphocytes of patients with lung cancer. Eur Respir J 2004; 24: Suppl. 48, 397

Member's Comments

No comment yet.

Related content which might interest you: Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Programmed death-1 T cells in lung cancer- a comparison of BALF cells from affected lung to healthy lung and peripheral blood Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 EpCAM-positive circulating cells in lung cancer patients Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Reciprocal imbalance or coexistence? The distribution of Th17 and Treg cells in peripheral blood lymphocytes in patients with non-small-cell lung cancer and its significance Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Apoptosis of bronchoalveolar lavage lymphocytes in hypersensitivity pneumonitis Source: Eur Respir J 2003; 21: 225-231 Year: 2003 Non-compartmentalisation of inflammatory cytokines in bronchoalveolar lavage T cells of stable lung transplant patients Source: Eur Respir J 2005; 26: Suppl. 49, 176s Year: 2005 The expression and clinical significance of PD-L1+CD68+ macrophages in peripheral blood mononuclear cells of non-small cell lung cancer Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Lower APCR correlates with apoptotic activation of CD8+T cells in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 356s Year: 2004 Tumor markers in bronchial secretions and serum in patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 76s Year: 2004 Relationship between blood monocyte subsets with activation markers and macrophages in non-small cell lung cancer Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Cellular changes in BAL fluid may reflect immunity in patients with lung cancer Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression Year: 2005 aEb7 integrin (CD103-b7) expression in bronchoalveolar T lymphocytes in interstitial lung diseases Source: Eur Respir J 2007; 30: Suppl. 51, 576s Year: 2007 Evaluation of dendritic cells in peripheral blood and pleural effusion of non-small-cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 529s Year: 2004 DNA damage in lymphocytes from COPD patients with and without lung cancer Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017 Increased BALF eosinophils and underlying interstitial lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005 Serum tumor markers in lung cancer patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007 Evaluation expression of miR-146a and miR-155 and inflammatory  cytokines in blood of non-small cell lung cancer patients Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021